Search by Drug Name or NDC
NDC 16110-0391-05 Klisyri 10 mg/g Details
Klisyri 10 mg/g
Klisyri is a TOPICAL OINTMENT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Almirall, LLC. The primary component is TIRBANIBULIN.
MedlinePlus Drug Summary
Tirbanibulin is used to treat actinic keratosis (flat, scaly growths on the skin caused by too much sun exposure) on the face or scalp. Tirbanibulin is in a class of medications called microtubule inhibitors. It works by killing fast-growing cells such as the abnormal cells associated with actinic keratoses.
Related Packages: 16110-0391-05Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Tirbanibulin Topical
Product Information
| NDC | 16110-0391 |
|---|---|
| Product ID | 16110-391_70dad989-cb85-41d4-8407-306d12bb49c2 |
| Associated GPIs | 90374580004220 |
| GCN Sequence Number | 081776 |
| GCN Sequence Number Description | tirbanibulin OINT PACK 1 % TOPICAL |
| HIC3 | Q5N |
| HIC3 Description | TOPICAL ANTINEOPLASTIC PREMALIGNANT LESION AGENTS |
| GCN | 48994 |
| HICL Sequence Number | 047031 |
| HICL Sequence Number Description | TIRBANIBULIN |
| Brand/Generic | Brand |
| Proprietary Name | Klisyri |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | tirbanibulin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | OINTMENT |
| Route | TOPICAL |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/g |
| Substance Name | TIRBANIBULIN |
| Labeler Name | Almirall, LLC |
| Pharmaceutical Class | Microtubule Inhibition [PE], Microtubule Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA213189 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 16110-0391-05 (16110039105)
| NDC Package Code | 16110-391-05 |
|---|---|
| Billing NDC | 16110039105 |
| Package | 5 PACKET in 1 CARTON (16110-391-05) / .25 g in 1 PACKET |
| Marketing Start Date | 2020-12-14 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |